Matritech makes progress with cancer diagnostics
This article was originally published in Clinica
Executive Summary
Matritech has moved a step closer to the US market with its doctor's office urine test for bladder cancer, after filing the product with the FDA. In a separate announcement the company said it is also making progress with its blood test for prostate cancer, following the initiation of a multicentre clinical trial.